| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |